Abbott Laboratories (ABT) News Today $113.42 -0.65 (-0.57%) (As of 10/29/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period These Are The Top Health Stocks to Own for Buy-and-Hold InvestingThe stocks on this list are the top three buy-and-hold stocks in healthcare, producing significant value for shareholders while leading their respective fields.October 30 at 8:36 AM | marketbeat.comAvitas Wealth Management LLC Sells 6,217 Shares of Abbott Laboratories (NYSE:ABT)Avitas Wealth Management LLC cut its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 22.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 22,048 shares of the healthcare product makerOctober 30 at 8:17 AM | marketbeat.comAbbott Laboratories Q3 Earnings TranscriptOctober 30 at 7:03 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Trading Up 0.4% - Should You Buy?Abbott Laboratories (NYSE:ABT) Trading 0.4% Higher - Time to Buy?October 29 at 3:01 PM | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Purchased by MONECO Advisors LLCMONECO Advisors LLC boosted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 110.1% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 31,148 shares of the healthcare product maker's stock after buying an additional 16,325 sharOctober 29 at 10:29 AM | marketbeat.comTidepool Will Integrate With Abbott's FreeStyle Libre Portfolio for Seamless Cloud-to-Cloud DataOctober 28 at 5:32 PM | businesswire.comAbbott Laboratories (NYSE:ABT) Trading 0.2% Higher - Still a Buy?Abbott Laboratories (NYSE:ABT) Trading Up 0.2% - Time to Buy?October 28 at 4:07 PM | marketbeat.comTCI Wealth Advisors Inc. Decreases Stock Holdings in Abbott Laboratories (NYSE:ABT)TCI Wealth Advisors Inc. cut its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 40.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,393 shares of the healthcare product maker's stock afOctober 28 at 12:29 PM | marketbeat.comCORRECTING and REPLACING Tidepool Will Integrate With Abbott's FreeStyle Libre Portfolio for Seamless Cloud-to-Cloud DataOctober 28 at 9:54 AM | businesswire.comAbbott Laboratories (NYSE:ABT) Shares Sold by DekaBank Deutsche GirozentraleDekaBank Deutsche Girozentrale cut its position in Abbott Laboratories (NYSE:ABT - Free Report) by 3.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,543,279 shares of the healthcare product maker'October 27 at 7:31 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Stock Price Down 1.1% - Here's What HappenedOctober 27 at 4:49 AM | americanbankingnews.comAbbott Laboratories (NYSE:ABT) Shares Sold by Sageworth Trust CoSageworth Trust Co trimmed its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 18.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 51,848 shares of the healthcare product maker's stock after sellingOctober 26, 2024 | marketbeat.com3 Dividend Growth Stocks You Can Buy and Hold ForeverOctober 26, 2024 | fool.comAbbott Laboratories (NYSE:ABT) Shares Down 1.1% - Here's WhyAbbott Laboratories (NYSE:ABT) Trading Down 1.1% - Here's What HappenedOctober 25, 2024 | marketbeat.comMediolanum International Funds Ltd Sells 25,977 Shares of Abbott Laboratories (NYSE:ABT)Mediolanum International Funds Ltd lowered its position in Abbott Laboratories (NYSE:ABT - Free Report) by 12.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 179,802 shares of the healthcare product maker's stock after selling 25,9October 25, 2024 | marketbeat.comFeganScott Launches Investigation into Abbott Laboratories Employees Credit Union Data BreachOctober 24, 2024 | globenewswire.comAbbott Laboratories (NYSE:ABT) Trading Down 0.4% - Here's What HappenedAbbott Laboratories (NYSE:ABT) Stock Price Down 0.4% - Here's WhyOctober 24, 2024 | marketbeat.comAssenagon Asset Management S.A. Sells 123,584 Shares of Abbott Laboratories (NYSE:ABT)Assenagon Asset Management S.A. reduced its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 5.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,277,606 shares of the healthcare product maker's stock after sellingOctober 24, 2024 | marketbeat.comAbbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart FailureOctober 24, 2024 | prnewswire.comOrganic Growth and Margin Expansion Make Abbott Laboratories (ABT) A Solid InvestmentOctober 23, 2024 | msn.comFederman & Sherwood Investigates Abbott Laboratories Employees Credit Union (“ALEC”) for Data BreachOctober 23, 2024 | businesswire.comCourier Capital LLC Has $3.90 Million Stake in Abbott Laboratories (NYSE:ABT)Courier Capital LLC lifted its position in Abbott Laboratories (NYSE:ABT - Free Report) by 51.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 34,245 shares of the healthcare product maker's stock afOctober 23, 2024 | marketbeat.comAbbott Laboratories: Promising Growth, Yet Fully Valued; A Wait-And-Watch StockOctober 23, 2024 | seekingalpha.comWilliam Blair Analysts Increase Earnings Estimates for ABTOctober 23, 2024 | americanbankingnews.comAbbott Laboratories (NYSE:ABT) Trading Down 0.2% - What's Next?Abbott Laboratories (NYSE:ABT) Trading Down 0.2% - Here's WhyOctober 22, 2024 | marketbeat.comEastern Bank Purchases 48,300 Shares of Abbott Laboratories (NYSE:ABT)Eastern Bank boosted its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 151.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 80,161 shares of the healthcare product maker's stock afterOctober 22, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) Trading Down 1.7% - Here's WhyAbbott Laboratories (NYSE:ABT) Shares Down 1.7% - Time to Sell?October 21, 2024 | marketbeat.comBorder to Coast Pensions Partnership Ltd Acquires 15,816 Shares of Abbott Laboratories (NYSE:ABT)Border to Coast Pensions Partnership Ltd grew its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 4.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 370,739 shares of the healthcare product maker's stock after acqOctober 21, 2024 | marketbeat.comAbbott Laboratories: Long-Term Optimism, Short-Term OvervaluationOctober 21, 2024 | seekingalpha.comAbbott Laboratories (NYSE:ABT) Price Target Raised to $117.00October 21, 2024 | americanbankingnews.comWilliam Blair Issues Optimistic Forecast for ABT EarningsAbbott Laboratories (NYSE:ABT - Free Report) - Investment analysts at William Blair raised their Q3 2025 EPS estimates for Abbott Laboratories in a report issued on Thursday, October 17th. William Blair analyst M. Kaczor now forecasts that the healthcare product maker will post earnings per shareOctober 21, 2024 | marketbeat.comAbbott Laboratories (ABT): Strong Q2 Performance and Innovative Product ApprovalsOctober 20, 2024 | msn.comVest Financial LLC Acquires 53,887 Shares of Abbott Laboratories (NYSE:ABT)Vest Financial LLC increased its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 12.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 470,358 shares of the healthcare product maker's stockOctober 20, 2024 | marketbeat.comMizuho Boosts Abbott Laboratories (NYSE:ABT) Price Target to $130.00October 20, 2024 | americanbankingnews.comAbbott Laboratories (NYSE:ABT) Price Target Raised to $146.00 at UBS GroupOctober 20, 2024 | americanbankingnews.comAbbott Laboratories (NYSE:ABT) Given New $125.00 Price Target at Jefferies Financial GroupOctober 20, 2024 | americanbankingnews.comAbbott Laboratories (NYSE:ABT) Stock Price Up 0.6% on Analyst UpgradeOctober 20, 2024 | americanbankingnews.comFerguson Wellman Capital Management Inc. Sells 262,042 Shares of Abbott Laboratories (NYSE:ABT)Ferguson Wellman Capital Management Inc. lowered its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 55.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21October 19, 2024 | marketbeat.comCiti Keeps Their Buy Rating on Abbott Laboratories (ABT)October 19, 2024 | markets.businessinsider.comWant Decades of Passive Income? 2 Stocks to Buy Now and Hold ForeverOctober 19, 2024 | fool.comAbbott Laboratories: Buy Rating Reaffirmed Amid Strong Medical Device Performance and Positive Long-Term Growth OutlookOctober 19, 2024 | markets.businessinsider.comMarketBeat Week in Review – 10/14 - 10/18 (ABT)Stocks struggled for direction, but the trend before tech earnings is still bullish. Nevertheless, investors should expect volatility ahead of the election.October 19, 2024 | marketbeat.comAbbott Laboratories: Strong Buy Rating Driven by Robust Growth Prospects and Operational ImprovementsOctober 19, 2024 | markets.businessinsider.comAbbott Laboratories (NYSE:ABT) Stock Price Up 0.6% After Analyst UpgradeAbbott Laboratories (NYSE:ABT) Stock Price Up 0.6% After Analyst UpgradeOctober 18, 2024 | marketbeat.comFY2024 Earnings Estimate for ABT Issued By William BlairAbbott Laboratories (NYSE:ABT - Free Report) - Analysts at William Blair lifted their FY2024 earnings estimates for shares of Abbott Laboratories in a research note issued on Thursday, October 17th. William Blair analyst M. Kaczor now forecasts that the healthcare product maker will post earningsOctober 18, 2024 | marketbeat.comSumitomo Mitsui DS Asset Management Company Ltd Has $22.77 Million Stake in Abbott Laboratories (NYSE:ABT)Sumitomo Mitsui DS Asset Management Company Ltd raised its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 5.8% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 199,683 shares of the healthcare product makerOctober 18, 2024 | marketbeat.com3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right NowOctober 18, 2024 | fool.comAbbott Laboratories (NYSE:ABT) Shares Down 0.3% - Should You Sell?Abbott Laboratories (NYSE:ABT) Trading Down 0.3% - Here's What HappenedOctober 17, 2024 | marketbeat.comAbbott Labs Path to Double-Digit Earnings Growth In 2025? This Analyst Is OptimisticOctober 17, 2024 | benzinga.comAbbott Laboratories (NYSE:ABT) Price Target Raised to $138.00Sanford C. Bernstein increased their target price on shares of Abbott Laboratories from $133.00 to $138.00 and gave the stock an "outperform" rating in a research report on Thursday.October 17, 2024 | marketbeat.com Get Abbott Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter. Email Address This is treason (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soon Click here to watch it now. ABT Media Mentions By Week ABT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABT News Sentiment▼0.710.67▲Average Medical News Sentiment ABT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABT Articles This Week▼2217▲ABT Articles Average Week Get Abbott Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ISRG News NVS News AZN News PFE News SYK News SNY News MRK News BSX News VRTX News MDT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABT) was last updated on 10/30/2024 by MarketBeat.com Staff From Our Partners625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredThe most serious warning of my careerWith the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the ...Porter & Company | SponsoredThis biotech's ONE drug could change medicine as we know itThis Clinical-stage Biotech Company is Taking a Revolutionary Approach to Eradicating Many Respiratory Viruses...Smallcaps Daily | Sponsored2 Pro Traders… 4 Livestreams… 4 Live TradesThe Zero Day Loophole: The Secret of HUGE Overnight Profits from Government ReportsMonument Traders Alliance | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredIs your portfolio prepared for AI 2.0?AI has exploded ever since ChatGPT set the world on fire near the end of 2022. Numerous companies with conn...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThe Death Knell for U.S. StocksThey are among the 31 billionaires dumping their stocks at a record pace. Fortune calls this phenomenon "Th...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abbott Laboratories Please log in to your account or sign up in order to add this asset to your watchlist. Share Abbott Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABT Stock Alerts